B
086820
vs
K
KOSPI 200
Over the past 12 months, Bio Solution Co Ltd has underperformed KOSPI 200, delivering a return of -25% compared to KOSPI 200's +152% growth.
Stocks Performance
086820 vs KOSPI 200
Performance Gap
086820 vs KOSPI 200
Performance By Year
086820 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bio Solution Co Ltd
Glance View
Bio Solution Co Ltd is a Korean biotechnology company that develops and sells products used in healthcare and life science settings. Its business is centered on making biological materials, tests, or related medical products that help labs, hospitals, and other health care customers diagnose or manage disease. In simple terms, it sits in the middle of the biotech supply chain, turning research and medical know-how into usable products. The company makes money by selling those products to medical institutions, research organizations, and other business customers that need reliable bio-based tools and supplies. Depending on the product line, revenue can come from direct product sales, repeat orders for consumables, and related service or support work tied to its technology. That kind of model tends to reward companies that can build trust with customers and keep products consistent. What makes Bio Solution different is that it is not a broad hospital chain or a drugmaker selling one blockbuster medicine. It focuses on specialized bio products, where technical know-how, quality control, and customer relationships matter a lot. That gives it a more niche role in the market: it earns its place by supplying the tools and materials that other healthcare and biotech businesses use every day.
